FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks
Currently predicting for Mon, 3 Jun 2024

Trading levels for EVOK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.542 14.18 %
R2 0.513 8.06 %
R1 0.495 4.29 %
Current price: 0.475
Support S1 0.437 -7.94 %
S2 0.419 -11.71 %
S3 0.390 -17.82 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.593 24.84 %
R2 0.590 24.21 %
R1 0.540 13.71 %
Current price 0.475
Support S1 0.470 -1.05%
S2 0.465 -2.11%
S3 0.451 -5.05%

EVOK Predictions History

7 years ago
turki predicted that EVOK for 2017-02-14 is going $2.75 (5.36%)

Rank:

7 years ago
JS predicted that EVOK for 2017-02-01 is going $2.65 (-5.69%)

7 years ago
Liam.Siegler.2602 predicted that EVOK for 2017-02-01 is going $3.00 (6.76%)

Rank:

7 years ago
Liam.Siegler.2602 predicted that EVOK for 2017-01-31 is going $1.31 (-54.04%)

Rank:

7 years ago
JS predicted that EVOK for 2017-01-13 is going $2.23 (-5.11%)

7 years ago
StockInvest predicted that EVOK for 2016-08-16 is going $2.92 (12.31%)

Click to get the best stock tips daily for free!

About Evoke Pharma

Evoke Pharma Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine ... EVOK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT